Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.
Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group study.
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats.
Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
Biologic and chemical effects of cis-dichlorodiammineplatinum (II) (NSC-119875) on DNA.
Clinical trials of cis-diamminedichloroplatinum (NSC-119875).
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.